159 related articles for article (PubMed ID: 37311536)
1. Neuro-Ophthalmic Visual Impairment in the Setting of COVID-19.
Dinkin M; Sathi S
Semin Neurol; 2023 Apr; 43(2):268-285. PubMed ID: 37311536
[TBL] [Abstract][Full Text] [Related]
2. Efferent neuro-ophthalmic complications of coronavirus disease 2019.
Dinkin M; Sathi S
Curr Opin Ophthalmol; 2022 Nov; 33(6):471-484. PubMed ID: 36165417
[TBL] [Abstract][Full Text] [Related]
3. Optic neuropathies post-Covid 19 - review.
Abdul-Salam State SE; Sfredel V; Mocanu CL; Albu CV; Bălășoiu AT
Rom J Ophthalmol; 2022; 66(4):289-298. PubMed ID: 36589322
[TBL] [Abstract][Full Text] [Related]
4. Afferent and Efferent Neuro-Ophthalmic Complications of Coronavirus Disease 19.
Tisdale AK; Dinkin M; Chwalisz BK
J Neuroophthalmol; 2021 Jun; 41(2):154-165. PubMed ID: 33935220
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review.
Vosoughi AR; Ling J; Tam KT; Blackwood J; Micieli JA
Br J Ophthalmol; 2021 Nov; 105(11):1591-1598. PubMed ID: 32998905
[TBL] [Abstract][Full Text] [Related]
6. Neuro-ophthalmological Presentation of Optic Neuritis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Lin TY; Asseyer S; Buenrostro GS; Feldmann K; Hamann S; Paul F; Zimmermann HG
Klin Monbl Augenheilkd; 2022 Nov; 239(11):1305-1314. PubMed ID: 35995144
[TBL] [Abstract][Full Text] [Related]
7. MOG-IgG positive optic neuritis after SARS-CoV-2 infection.
Gilardi M; Cortese A; Ferraro E; Rispoli M; Sadun R; Altavista MC; Sadun F
Eur J Ophthalmol; 2023 Sep; 33(5):NP87-NP90. PubMed ID: 36317310
[TBL] [Abstract][Full Text] [Related]
8. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
[TBL] [Abstract][Full Text] [Related]
9. Neuroradiologic Imaging of Neurologic and Neuro-Ophthalmic Complications of Coronavirus-19 Infection.
Marsiglia M; Chwalisz BK; Maher M
J Neuroophthalmol; 2021 Dec; 41(4):452-460. PubMed ID: 34788237
[TBL] [Abstract][Full Text] [Related]
10. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
12. Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis.
Chun BY; Cestari DM
Curr Opin Ophthalmol; 2018 Nov; 29(6):508-513. PubMed ID: 30281030
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
[TBL] [Abstract][Full Text] [Related]
14. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT].
Almer Z
Harefuah; 2022 Oct; 161(10):645-651. PubMed ID: 36315205
[TBL] [Abstract][Full Text] [Related]
15. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
16. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.
Kogure C; Kikushima W; Fukuda Y; Hasebe Y; Takahashi T; Shibuya T; Sakurada Y; Kashiwagi K
Medicine (Baltimore); 2021 May; 100(19):e25865. PubMed ID: 34106635
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
18. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies.
Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ
Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199
[TBL] [Abstract][Full Text] [Related]
19. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]